Sky Investment Group LLC Abbott Laboratories Transaction History

Sky Investment Group LLC

  • $528 Million
  • Q4 2024

A detailed history of Sky Investment Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sky Investment Group LLC holds 105,924 shares of ABT stock, worth $14.6 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares
105,924
Previous 106,177 0.24%
Holding current value
$14.6 Million
Previous $12.1 Million 1.02%
% of portfolio
2.27%
Previous 2.26%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
SELL
$111.93 - $119.39 $28,318 - $30,205
-253 Reduced 0.24%
105,924 $12 Million
Q3 2024

Oct 21, 2024
SELL
$100.07 - $118.13 $157,209 - $185,582
-1,571 Reduced 1.46%
106,177 $12.1 Million
Q2 2024

Jul 16, 2024
SELL
$100.73 - $112.44 $48,249 - $53,858
-479 Reduced 0.44%
107,748 $11.2 Million
Q1 2024

Apr 23, 2024
SELL
$109.52 - $120.96 $108,424 - $119,750
-990 Reduced 0.91%
108,227 $12.3 Million
Q4 2023

Jan 24, 2024
SELL
$90.19 - $110.4 $81,802 - $100,132
-907 Reduced 0.82%
109,217 $12 Million
Q3 2023

Oct 26, 2023
SELL
$95.53 - $114.62 $20,347 - $24,414
-213 Reduced 0.19%
110,124 $10.7 Million
Q2 2023

Jul 25, 2023
SELL
$100.78 - $112.29 $367,645 - $409,633
-3,648 Reduced 3.2%
110,337 $12 Million
Q1 2023

Apr 25, 2023
SELL
$96.86 - $114.01 $106,933 - $125,867
-1,104 Reduced 0.96%
113,985 $11.5 Million
Q4 2022

Jan 27, 2023
SELL
$95.06 - $111.52 $16,445 - $19,292
-173 Reduced 0.15%
115,089 $12.6 Million
Q3 2022

Oct 25, 2022
BUY
$96.76 - $112.03 $40,832 - $47,276
422 Added 0.37%
115,262 $11.2 Million
Q2 2022

Jul 12, 2022
SELL
$102.07 - $123.37 $339,382 - $410,205
-3,325 Reduced 2.81%
114,840 $12.5 Million
Q1 2022

Apr 14, 2022
BUY
$114.02 - $139.04 $13,454 - $16,406
118 Added 0.1%
118,165 $14 Million
Q4 2021

Jan 24, 2022
BUY
$115.53 - $141.46 $15,018 - $18,389
130 Added 0.11%
118,047 $16.6 Million
Q3 2021

Nov 08, 2021
SELL
$116.66 - $129.06 $230,520 - $255,022
-1,976 Reduced 1.65%
117,917 $13.9 Million
Q2 2021

Jul 21, 2021
SELL
$105.79 - $124.53 $296,423 - $348,933
-2,802 Reduced 2.28%
119,893 $13.9 Million
Q1 2021

Apr 20, 2021
SELL
$108.84 - $128.23 $782,668 - $922,101
-7,191 Reduced 5.54%
122,695 $14.7 Million
Q4 2020

Jan 25, 2021
SELL
$105.0 - $114.42 $658,350 - $717,413
-6,270 Reduced 4.61%
129,886 $14.2 Million
Q3 2020

Oct 08, 2020
BUY
$91.64 - $111.29 $2.46 Million - $2.98 Million
26,799 Added 24.51%
136,156 $14.8 Million
Q2 2020

Jul 20, 2020
SELL
$76.57 - $98.0 $8,039 - $10,290
-105 Reduced 0.1%
109,357 $10 Million
Q1 2020

Apr 16, 2020
BUY
$62.82 - $91.86 $82,985 - $121,347
1,321 Added 1.22%
109,462 $8.64 Million
Q4 2019

Jan 13, 2020
SELL
$78.51 - $87.4 $24,495 - $27,268
-312 Reduced 0.29%
108,141 $9.39 Million
Q3 2019

Oct 25, 2019
SELL
$81.84 - $88.74 $119,486 - $129,560
-1,460 Reduced 1.33%
108,453 $9.07 Million
Q2 2019

Jul 16, 2019
SELL
$72.88 - $85.0 $10,932 - $12,750
-150 Reduced 0.14%
109,913 $9.24 Million
Q1 2019

Apr 18, 2019
SELL
$66.22 - $80.06 $40,659 - $49,156
-614 Reduced 0.55%
110,063 $0
Q4 2018

Jan 24, 2019
BUY
$65.56 - $74.27 $229,460 - $259,945
3,500 Added 3.27%
110,677 $8.01 Million
Q3 2018

Oct 11, 2018
SELL
$60.81 - $73.36 $19,824 - $23,915
-326 Reduced 0.3%
107,177 $7.86 Million
Q2 2018

Aug 20, 2018
BUY
$57.57 - $63.54 $54,115 - $59,727
940 Added 0.88%
107,503 $6.56 Million
Q1 2018

Apr 11, 2018
SELL
$56.27 - $63.62 $15,417 - $17,431
-274 Reduced 0.26%
106,563 $6.39 Million
Q4 2017

Jan 17, 2018
SELL
$53.68 - $57.47 $20,130 - $21,551
-375 Reduced 0.35%
106,837 $6.1 Million
Q3 2017

Oct 24, 2017
BUY
$48.06 - $53.64 $5.15 Million - $5.75 Million
107,212
107,212 $5.72 Million

Others Institutions Holding ABT

# of Institutions
3,370
Shares Held
1.36B
Call Options Held
10.6M
Put Options Held
8.73M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $241B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sky Investment Group LLC Portfolio

Follow Sky Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky Investment Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email